Gateway Analytical Senior Scientist Oksana Olkhovyk, Ph.D. recently presented at RDD Europe 2013 in Berlin, Germany. The workshop titled: "Automated Ingredient Specific Particle Sizing" is now available for download.
Original Event Date: Tuesday, June 4, 2013
Duration: 45 minutes
Presenters: David Exline, Senior Vice President at Gateway Analytical
Host: Shawn Wilhelm, Marketing Coordinator at Gateway Analytical
Respiratory Drug Delivery Europe 2013
Authors: Oksana Olkhovyk, Gateway Analytical, 5316 William Flynn Highway, Gibsonia, PA 15044
Release Date: Wed., May 22, 2013
It may seem a little nitpicky to point out the difference between conformance and compliance, validation and qualification, or even registered and certified. After all, how often is someone going to ask you to correctly define compliance and use it properly in a sentence? Unless your employer exercises their right to hand out pop quizzes, probably never.
Last week, I attended the annual meeting for the Mid-Atlantic Association of Forensic Scientists in Roanoke, Virginia. The meeting was held at the historic Hotel Roanoke and Conference Center, located in the Blue Ridge Mountains. Not only was the drive through the West Virginian mountain country beautiful, but the conference overall was a great experience.
On May 14th, Rebekah Byrne, Scientist I and David Exline, Senior Vice President at Gateway Analytical hosted a webinar designed for developers of parenteral drug products. During this webinar, our presenters identified commonly found contaminants in parenteral drug products, how these contaminants are introduced into the manufacturing process, how they can be detected both visibly and non-visibly and laboratory techniques used to identify contaminates. They provided insight into terminology used when discussing parenteral contamination including the difference between particle-free vs. sterile and the standards for visual inspection. They also discussed the importance of taking a pro-active approach to quickly source and manage contaminant issues in the manufacturing process to reduce the risk of future contamination and potentially save your company money by preventing potential recalls.
Original Event Date: Tuesday, May 14, 2013
Duration: 60 minutes
Presenters: David Exline, Senior Vice President & Rebekah Byrne, Scientist I at Gateway Analytical
Host: Shawn Wilhelm, Marketing Coordinator at Gateway Analytical
On April 30th, Dave Exline, Senior V.P. and Cara Plese, M.S., Scientist I at Gateway Analytical hosted a webinar designed for police and attorneys involved in cases with physical evidence. During this webinar, our presenters discussed the advantages of microscopic and presumptive screenings of physical evidence, especially suspected bodily fluid stains and hair prior to advancing to more expensive DNA analysis. They also provide examples of such screenings and discussed how these screening methods can save valuable time, money and resources by eliminating samples from being forwarded onto unnecessary further analysis.
The consultant is a valuable tool for any organization if properly utilized. The key to gaining the most benefit to using a consultant starts with the need. The need must be clearly identified as a one time need or ongoing need. The organization must first determine if the appropriate expertise is represented within the organization. If the specific expertise is present in house, then one must ask if outside help can add value to existing group. Often times for specific problems, a consultant may be the right approach.